ID

34590

Descrizione

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01941199

collegamento

https://clinicaltrials.gov/show/NCT01941199

Keywords

  1. 19/01/19 19/01/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

19 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Type 2 Diabetes Mellitus NCT01941199

Eligibility Type 2 Diabetes Mellitus NCT01941199

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
age between 20 to 45, healthy male subjects(at screening)
Descrizione

ID.1

Tipo di dati

boolean

body weight between 55kg - 90kg, bmi between 18.0 - 27.0
Descrizione

ID.2

Tipo di dati

boolean

fpg 70-125mg/dl glucose level(at screening)
Descrizione

ID.3

Tipo di dati

boolean

subject who totally understand the progress of this clinical trials, make decision by his free will, and signed a consent form to follow the progress.
Descrizione

ID.4

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject who has past or present history of any diseases following below.(liver including hepatitis virus carrier, kidney, neurology, immunology, pulmonary, endocrine, hematooncology, cardiology, mental disorder)
Descrizione

ID.5

Tipo di dati

boolean

subject who had gi tract disease(crohn's disease, ulcer, acute or chronic pancreatitis) or surgery(appendectomy, hernioplasty are excluded)
Descrizione

ID.6

Tipo di dati

boolean

subject who had drug(aspirin, antibiotics) hypersensitivity reaction
Descrizione

ID.7

Tipo di dati

boolean

subject who already participated in other trials in 2 months
Descrizione

ID.8

Tipo di dati

boolean

subject who had whole blood donation in 2 months, or component blood donation in 1 months or transfusion in 1 months currently.
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Type 2 Diabetes Mellitus NCT01941199

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age between 20 to 45, healthy male subjects(at screening)
boolean
ID.2
Item
body weight between 55kg - 90kg, bmi between 18.0 - 27.0
boolean
ID.3
Item
fpg 70-125mg/dl glucose level(at screening)
boolean
ID.4
Item
subject who totally understand the progress of this clinical trials, make decision by his free will, and signed a consent form to follow the progress.
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
subject who has past or present history of any diseases following below.(liver including hepatitis virus carrier, kidney, neurology, immunology, pulmonary, endocrine, hematooncology, cardiology, mental disorder)
boolean
ID.6
Item
subject who had gi tract disease(crohn's disease, ulcer, acute or chronic pancreatitis) or surgery(appendectomy, hernioplasty are excluded)
boolean
ID.7
Item
subject who had drug(aspirin, antibiotics) hypersensitivity reaction
boolean
ID.8
Item
subject who already participated in other trials in 2 months
boolean
ID.9
Item
subject who had whole blood donation in 2 months, or component blood donation in 1 months or transfusion in 1 months currently.
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial